<DOC>
	<DOC>NCT02210325</DOC>
	<brief_summary>This study will compare a single dose of oral solithromycin to the standard of care (intramuscular ceftriaxone plus oral azithromycin) in the treatment of patients with urogenital gonorrhea. A completed open-label Phase 2 study with single doses of solithromycin resulted in 100% microbiological eradication in male and female patients with uncomplicated urogenital gonorrhea.</brief_summary>
	<brief_title>Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea</brief_title>
	<detailed_description />
	<mesh_term>Gonorrhea</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<criteria>At least 1 of the following: 1. Untreated male with urethral gonorrhea as determined by a screening laboratory test (either NAAT or culture) for N. gonorrhoeae within 2 weeks prior to study drug administration. 2. Untreated female with cervical gonorrhea as determined by a screening laboratory test (either NAAT or culture) for N. gonorrhoeae within 2 weeks prior to study drug administration. 3. Urethral (male) or cervical (female) Gram stain demonstrating Gramnegative intracellular diplococci and leukocytes. The patient must be willing to abstain from anal, oral, and vaginal sexual intercourse or use condoms for all of these until study completion. Females of childbearing potential (including females less than 2 years postmenopausal) must have a negative pregnancy test at enrollment. Confirmed or suspected complicated or systemic gonococcal infections such as pelvic inflammatory disease, epididymitis, arthritis, endocarditis, or disseminated gonococcal infection. Individuals who have already received antibiotic treatment for their gonorrhea. Use of systemic or intravaginal antibiotics within 7 days prior to study drug administration. Women who are pregnant or nursing. Men with suspected or confirmed rectal gonorrhea and symptoms of proctitis. History of significant intolerance or allergy to macrolide or cephalosporin antibiotics.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>gonorrhea</keyword>
	<keyword>chlamydia</keyword>
	<keyword>solithromycin</keyword>
</DOC>